Bioventus Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BVS Nasdaq 3841 http://www.bioventus.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioventus Inc

Durham firm reworks $450M acquisition amid stock market volatility - Jun 22nd, 2022 9:00 am
Bioventus Amends CartiHeal Acquisition Structure - Jun 21st, 2022 11:30 am
Implied Volatility Surging for Bioventus (BVS) Stock Options - Jun 15th, 2022 12:33 pm
Bioventus Inc. (BVS) Q1 2022 Earnings Call Transcript - May 10th, 2022 5:00 pm
Bioventus Reports First Quarter Results; Reaffirms Full-Year 2022 Financial Guidance - May 10th, 2022 11:00 am
With markets shaky, Durham firm scraps $415M plan to fund acquisition - May 4th, 2022 6:54 pm
Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance - May 3rd, 2022 9:47 pm
Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis - May 2nd, 2022 11:00 am
Durham company needs to raise $415M for deal. Here's how it's doing it. - Apr 26th, 2022 6:59 pm
Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA - Apr 26th, 2022 1:05 pm
Bioventus Announces $415 Million Offering of Senior Notes - Apr 26th, 2022 12:38 pm
Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022 - Apr 25th, 2022 11:00 am
Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives - Apr 8th, 2022 1:15 pm
Some Investors May Be Worried About Bravura Solutions' (ASX:BVS) Returns On Capital - Apr 8th, 2022 2:12 am
Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton - Apr 5th, 2022 11:00 am
Bioventus Inc. (NASDAQ:BVS) Shares Could Be 47% Below Their Intrinsic Value Estimate - Apr 4th, 2022 9:36 pm
Durham public company adds to acquisition streak with $450M deal - Apr 4th, 2022 6:23 pm
Why Bioventus Stock Is Sinking Today - Apr 4th, 2022 3:27 pm
Bioventus Exercises Call Option to Acquire CartiHeal - Apr 4th, 2022 11:00 am
3 “Strong Buy” Stocks to Watch as 2Q22 Kicks Off - Apr 4th, 2022 1:10 am